Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (6): 990-993.doi: 10.16352/j.issn.1001-6325.2023.06.0990
• Mini Reviews • Previous Articles Next Articles
LIU Lei, DING Lan, YUAN Yuan, YE Jing*
Received:2022-02-25
Revised:2022-07-21
Online:2023-06-05
Published:2023-05-31
Contact:
*yejing@fmmu.edu.cn
CLC Number:
LIU Lei, DING Lan, YUAN Yuan, YE Jing. Advance on iron overload in liver diseases[J]. Basic & Clinical Medicine, 2023, 43(6): 990-993.
| [1] | Mori M, Izawa T, Inai Y, et al. Dietary iron overload differentially modulates chemically-induced liver injury in rats[J]. Nutrients, 2020, 12:2784-2798. |
| [2] | Handa P, Morgan-Stevenson V, Maliken B, et al. Iron overload results in hepatic oxidative stress, immune cell activation, and hepatocellular ballooning injury, leading to nonalcoholic steatohepatitis in genetically obese mice[J]. Am J Physiol Gastrointest Liver Physiol, 2016, 310:G117-G127. |
| [3] | Jo H, Yang J, Park J, et al. Endoplasmic reticulum stress increases DUSP5 expression via PERK-CHOP pathway, leading to hepatocyte death[J]. Int J Mol Sci, 2019, 20:4369-4380. |
| [4] | Chen C, Wu H, Ye H, et al. Activation of the unfolded protein response (UPR) is associated with cholangio-cellular injury, fibrosis and carcinogenesis in an experimental model of fibropolycystic liver disease[J]. Cancers, 2021, 14:78-99. |
| [5] | Wang Z, Li M, Liu Y, et al. Dihydroartemisinin triggers ferroptosis in primary liver cancer cells by promoting and unfolded protein response-induced upregulation of CHAC1 expression[J]. Oncol Rep, 2021, 46:240-253. |
| [6] | 李丹婷, 刘露路, 高茹菲, 等. 内质网应激参与双酚a导致小鼠的肝脏脂质沉积[J]. 基础医学与临床, 2016, 36:886-890. |
| [7] | Liu H, Lai W, Liu X, et al. Exposure to copper oxide nanoparticles triggers oxidative stress and endoplasmic reticulum(ER)-stress induced toxicology and apoptosis in male rat liver and brl-3a cell[J]. J Hazard Mater, 2021, 401:123349-123360. |
| [8] | Wu Z, Wang H, Fang S, et al. Roles of endoplasmic reticulum stress and autophagy on H2O2-induced oxidative stress injury in HepG2 cells[J]. Mol Med Rep, 2018, 18:4163-4174. |
| [9] | Wu A, Feng B, Yu J, et al. Fibroblast growth factor 21 attenuates iron overload-induced liver injury and fibrosis by inhibiting ferroptosis[J]. Redox Biol, 2021, 46:102131-102142. |
| [10] | Protchenko O, Baratz E, Jadhav S, et al. Iron chaperone Poly rC binding protein 1 protects mouse liver from lipid peroxidation and steatosis[J]. Hepatology, 2021, 73:1176-1193. |
| [11] | Jahng J, Alsaadi R, Palanivel R, et al. Iron overload inhibits late stage autophagic flux leading to insulin resistance[J]. EMBO Rep, 2019, 20:7911-7928. |
| [12] | Maras J, Das S, Sharma S, et al. Iron-overload triggers ADAM-17 mediated inflammation in severe alcoholic hepatitis[J]. Sci Rep, 2018, 8:10264-10277. |
| [13] | Tang Y, Wang D, Niu X, et al. Mild iron overload induces TRIP12-mediated degradation of YY1 to trigger hepatic inflammation[J]. Free Radical Bio Med, 2020, 161:187-197. |
| [14] | Alajeel N, Shehab M, Francis I, et al. A rare cause of chronic liver disease diagnosed by endoscopic ultrasound-guided liver biopsy[J]. Am J Case Rep, 2021,22:e933002.doi:10.12659/AJCR:933002.doi:10.3389/fmolb.2020.00007. |
| [15] | Maffei L, Sorrentino F, Caprari P, et al. HCV infection in thalassemia syndromes and hemoglobinopathies: new perspectives[J]. Front Mol Biosci, 2020, 7:7.doi:10.3389/fmolb.2020.00007. |
| [16] | Kühn J, Meffert P, Heske C, et al. Prevalence of fatty liver disease and hepatic iron overload in a northeastern German population by using quantitative MR imaging[J]. Radiology, 2017, 284:706-716. |
| [17] | Buzzetti E, Petta S, Manuguerra R, et al. Evaluating the association of serum ferritin and hepatic iron with disease severity in non-alcoholic fatty liver disease[J]. Liver Int, 2019, 39:1325-1334. |
| [18] | Eder S, Feldman A, Strebinger G, et al. Mesenchymal iron deposition is associated with adverse long-term outcome in non-alcoholic fatty liver disease[J]. Liver Int, 2020, 40:1872-1882. |
| [19] | Handa P, Thomas S, Morgan-Stevenson V, et al. Iron alters macrophage polarization status and leads to steatohepatitis and fibrogenesis[J]. J Leukoc Biol, 2019, 105:1015-1026. |
| [20] | Corradini E, Buzzetti E, Dongiovanni P, et al. Ceruloplasmin gene variants are associated with hyperferritinemia and increased liver iron in patients with NAFLD[J]. J Hepatol, 2021, 75:506-513. |
| [21] | Zhu M, Chen H, Zhou S, et al. Iron oxide nanoparticles aggravate hepatic steatosis and liver injury in nonalcoholic fatty liver disease through BMP-SMAD-mediated hepatic iron overload[J]. Nanotoxicology, 2021, 15:761-778. |
| [22] | Muto Y, Moroishi T, Ichihara K, et al. Disruption of FBXL5-mediated cellular iron homeostasis promotes liver carcinogenesis[J]. J Exp Med, 2019, 216:950-965. |
| [23] | de Campos WN, Massaro J, Cançado E, et al. Comprehensive analysis of HFE gene in hereditary hemochro-matosis and in diseases associated with acquired iron overload[J]. World J Hepatol, 2019, 11:186-198. |
| [24] | Chung J, Shin E, Kim H, et al. Hepatic iron overload in the portal tract predicts poor survival in hepatocellular carcinoma after curative resection[J]. Liver Int, 2018, 38:903-914. |
| [25] | Gao R, Kalathur R, Coto-Llerena M, et al. YAP/TAZ and ATF4 drive resistance to Sorafenib in hepatocellular carcinoma by preventing ferroptosis[J]. EMBO Mol Med, 2021, 13:e14351.doi:10.15252/emmm.202114351. |
| [1] | HAO Yifei, CHEN Shuohua, YANG Chenlu, ZHOU Di, YE Qingfeng, WU Shouling, WANG Li. Clinical application of RASi and risk of all-cause mortality in patients with steatotic liver disease and hypertension [J]. Basic & Clinical Medicine, 2026, 46(5): 629-636. |
| [2] | XU Xia, WANG Fubing, ZHAO Peipei, FAN Hui, LI Xin, ZHANG Gu, GU Xinhong. Therapeutic effects of Sofren injection on non-alcoholic fatty liver disease in rat models [J]. Basic & Clinical Medicine, 2026, 46(3): 367-373. |
| [3] | LONG Fangwen, ZHENG Xia, QIAN Jun, ZHANG Yifen. Research progress on the mechanisms of omental metastasis in gastric cancer [J]. Basic & Clinical Medicine, 2026, 46(2): 282-287. |
| [4] | XIAO Yanxin, LIU Yan, XU Lingling, ZHOU Yaru. Research progress on the role of ferroptosis in the pathogenesis of non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2024, 44(2): 260-264. |
| [5] | LI Xiang, LI Ye. Research progress on the interaction between autophagy and ferroptosis in non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2023, 43(8): 1294-1298. |
| [6] | WANG Xinrui, QIN Yan. Research advances of Ghrelin in metabolic diseases [J]. Basic & Clinical Medicine, 2023, 43(8): 1299-1303. |
| [7] | HAO Dandan, ZHANG Lei, BAI Chunying. Research progress of drugs targeting ferroptosis for the treatment of non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2023, 43(8): 1317-1321. |
| [8] | HUANG Lichenlu, ZHANG Jiarui, ZHENG Yongqin, HE Jundong. Research progress of sodium-glucose cotransporter 2 inhibitor in non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2023, 43(10): 1594-1598. |
| [9] | ZHOU Jiahang, CHEN Junyao, CAO Hongcui. Research progress of mesenchymal stem cells in the treatment of liver disease [J]. Basic & Clinical Medicine, 2023, 43(1): 12-20. |
| [10] | SHI Dong-xue, YUAN Jia-qi, DING Bao-feng, WAGN Xiao-shuang, YU Jia. Liver pathological changes and hepatocyte acquisition method of model mice with non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2022, 42(6): 890-895. |
| [11] | HU Shi-qi, LAN Yan-qi, WU Shou-ling, WANG Xiao-mo, CHEN Shuo-hua, WANG Guo-dong, WANG Li. Effect of obesity and obesity trajectories on the risk of cardiovascular diseases in adult male with incident NAFLD in Northern China [J]. Basic & Clinical Medicine, 2022, 42(5): 788-794. |
| [12] | CHEN Chun-mei, GE Pin, GUO Chong. Iron metabolism in human body and its regulatory factors [J]. Basic & Clinical Medicine, 2022, 42(5): 818-823. |
| [13] | XU Ke, HU Xiang, YU Wei-hui, YANG Li-juan, GU Xue-jiang. Relationship between metabolically healthy obesity and the prevalence of non-alcoholic fatty liver disease [J]. Basic & Clinical Medicine, 2021, 41(6): 837-841. |
| [14] | XIAO Feng-qin, ZHANG Hong-yin, HAN Rong-xin, ZHANG Rong-rong, YAN Ming-ming, ZHANG Shi-yang, JIA Xiu-xiu. Ziziphi Spinosae Semen Flavonoids alleviates liver oxidative damage induced by perfluorooctane sulfonate in mice [J]. Basic & Clinical Medicine, 2021, 41(2): 184-188. |
| [15] | ZHANG Ruo-xi, LI Hong-min, WU Jie, HAN Bing. Clinical significance of testing blood parameters on the diagnosis of common microcytic anemia patients [J]. Basic & Clinical Medicine, 2020, 40(1): 105-109. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||